How does space radiation affect astronauts' health?
Space radiation exposure grows with mission length and distance, and the main health worry is total career dose.
Covers: This page covers the types and sources of space radiation, estimated astronaut doses on missions, and the evidence linking radiation exposure to cancer, cardiovascular, central nervous system, and other health outcomes. It does not cover spacecraft shielding engineering or mission planning in detail.
3 free full reads left this month. Join or upgrade
The short answer
Evidence-backed AI-prepared starting mapSpace radiation is ionizing radiation that astronauts encounter beyond the protection of Earth's magnetic field, and the health concern is cumulative dose over a career. A six-month International Space Station mission delivers roughly 72 mSv, while a three-year Mars mission could exceed 1000 mSv. Cancer risk from ionizing radiation is well documented at doses from about 100 mSv upward, and the current NASA standard sets a universal career-effective dose limit of 600 mSv regardless of sex or age. Beyond cancer, deep-space particle radiation (high-energy and high atomic number, HZE) is linked to cardiovascular and central nervous system concerns, though much of the mechanism-level evidence comes from animal models rather than astronauts.1234
- Evidence 18
In brief
Dose scales with mission length and distance: about 72 mSv on a six-month ISS mission versus potentially over 1000 mSv on a three-year Mars mission.1
Evidence-backedRecent revisions of the NASA Space Cancer Risk model and non-targeted effect scenarios suggest exploration mission risks may be higher than previously estimated.2
Evidence-backedCardiovascular effects documented in spaceflight include dysrhythmias, altered vascular compliance, dysautonomia, and a pro-inflammatory state.3
Evidence-backedCognitive, neurodegenerative, and gastrointestinal effects of space-relevant radiation are supported mainly by animal studies and still need validation in humans.4
Evidence-backed
At a glance
The picture in numbers
Live · updated just now
- Six-month ISS mission72 mSv
- Three-year Mars mission1,000 mSv
600 mSv
100 mSv
The evidence behind it
4 sources- Other studies and data3
- Background1
Published in 2026
| Source | Kind | Year |
|---|---|---|
| Space Radiation and Cancer Risk in Astronauts: Models, Evidence, Uncertainties, and Emerging Imaging Perspectives. | Other studies and data | 2026 |
| Cardiovascular risks and hazards associated with deep space exploration. | Other studies and data | 2026 |
| Space radiation health risks to hematopoietic, neural, and gastrointestinal systems in astronauts. | Other studies and data | 2026 |
| Effects of ionizing radiation in spaceflight (Wikipedia) | Background | Unknown |
The community around it
- Contributions
- 0
- People
- 0
- Following
- 0
Nobody has added anything yet. Experience, evidence or a different view would show up here.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If you want a quick sense of how much radiation a mission involves
compare mission length and destination: roughly 72 mSv for six months on the ISS versus potentially over 1000 mSv for a three-year Mars mission.1
Evidence-backedIf you are weighing cancer risk from space radiation
note that documented risk begins around 100 mSv, that NASA applies a universal 600 mSv career-effective dose limit regardless of sex or age, and that recent model revisions suggest exploration risks may be higher than earlier estimates.12
Evidence-backedIf you are concerned about heart effects
the documented spaceflight cardiovascular effects are dysrhythmias, altered vascular compliance, dysautonomia, and a pro-inflammatory state, but how these play out on exploration missions is not yet known.3
Evidence-backedIf you read about cognitive or gut effects of space radiation
treat them as animal-model findings not yet validated in astronauts, with proposed mechanisms including impaired hippocampal synaptic plasticity, neuroinflammation, mitochondrial imbalance, and gut-brain axis signaling.4
Evidence-backedIf you need to judge how firm a risk estimate is
account for substantial uncertainty in high-LET radiobiology, mixed-field exposure, and transferring terrestrial epidemiological data to spaceflight.2
Evidence-backedThe full story · 4 chapters
01
Radiation types and estimated astronaut doses
AI summary:Explains space radiation types and gives estimated astronaut doses for ISS and Mars missions.
Evidence-backed: Space flight exposes astronauts to microgravity, ionizing radiation, and other stressors. Beyond low Earth orbit, crews face different types and quantities of particle radiation, including high-energy and high atomic number (HZE) particles, along with isolation, confinement, sleep disruption, and limited access to medical help and supplies. Without Earth's magnetic field, the rate of exposure rises dramatically.31
Evidence-backed: On dose: astronauts receive approximately 72 mSv during six-month ISS missions, while three-year Mars missions could expose them to radiation in excess of 1000 mSv. The cancer risk from ionizing radiation is well documented at doses beginning at 100 mSv and above. For comparison, atomic bomb survivors in Hiroshima and Nagasaki, nuclear reactor workers, and patients receiving therapeutic radiation have received low-linear energy transfer (LET) radiation (x-rays and gamma rays) in the same 50–2,000 mSv range.1
02
Cancer risk: models, standards, and uncertainty
AI summary:Covers cancer risk models, NASA's dose standard, and remaining uncertainty in estimates.
Evidence-backed: Earlier risk-of-exposure-induced-death (REID) models suggested the historical 3% REID threshold could be exceeded after roughly 18 months in women and 24 months in men under unfavorable solar conditions. The current NASA radiation standard instead uses a universal career-effective dose limit of 600 mSv, applied regardless of sex or age. More recent revisions of the NASA Space Cancer Risk model and non-targeted effect scenarios suggest exploration mission risks may be higher than previously estimated.2
Evidence-backed: Uncertainty in these estimates remains substantial, particularly for high-LET radiobiology, mixed-field exposure, and the transfer of terrestrial epidemiological data to the spaceflight setting. Quantitative imaging biomarkers and tomographic assessments are being explored as complementary tools for longitudinal monitoring and early detection of radiation-related tissue changes, but they are not yet validated as components of operational astronaut cancer risk models.2
03
Cardiovascular effects
AI summary:Lists known cardiovascular effects of space travel and open questions for deep-space missions.
Evidence-backed: Known effects of space travel on the cardiovascular system include dysrhythmias, altered vascular compliance, dysautonomia, and induction of a pro-inflammatory state. Deep-space missions to the Moon (NASA's Artemis and Gateway programs), Mars, and beyond will introduce prolonged exposure to hazards including particle radiation, and it is not known how these concerns, and other potentially unknown cardiovascular risks, will manifest during and after exploration-type missions.3
04
Central nervous system and gastrointestinal findings
AI summary:Describes animal-model findings on cognitive, neural, and gut effects of space radiation.
Evidence-backed: Preclinical animal model research indicates that even low doses of space-relevant radiation may induce cognitive decline, memory deficits, anxiety-like behaviors, and neurodegenerative alterations, though these findings remain to be validated in human astronauts. Proposed mechanisms include impaired hippocampal synaptic plasticity, neuroinflammatory activation, and mitochondrial energy metabolism imbalance.4
Evidence-backed: Radiation has been shown to compromise the intestinal epithelial barrier, induce intestinal stem cell senescence, and disturb gut microbiome equilibrium in preclinical models. Based on mechanistic evidence from animal studies, these gastrointestinal alterations may potentially exacerbate neurocognitive dysfunction and promote chronic inflammation via the gut-brain axis.4
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Effects of ionizing radiation in spaceflight (Wikipedia)WikipediaPublished Oct 1, 2026Checked Oct 4, 2026
“Astronauts are exposed to approximately 72 millisieverts (mSv) while on six-month-duration missions to the International Space Station (ISS). Longer 3-year missions to Mars, however, have the potential to expose astronauts to radiation in excess of 1000 mSv. Without the protection provided by Earth's magnetic field, the rate of exposure is dramatically increased. The risk of cancer caused by ionizing radiation is well documented at radiation doses beginning at 100 mSv and above. Related radiological effect studies have shown that survivors of the atomic bomb explosions in Hiroshima and Nagasaki, nuclear reactor workers and patients who have undergone therapeutic radiation treatments have received low-linear energy transfer (LET) radiation (x-rays and gamma rays) doses in the same 50-2,000 mSv range.”
- 2Space Radiation and Cancer Risk in Astronauts: Models, Evidence, Uncertainties, and Emerging Imaging Perspectives.Tomography (Ann Arbor, Mich.) (Zanon et al.)Published Jul 17, 2026Checked Oct 4, 2026
“Earlier REID-based models suggested that the historical 3% REID threshold could be exceeded after approximately 18 months in women and 24 months in men under unfavorable solar conditions, whereas the current NASA radiation standard uses a universal career-effective dose limit of 600 mSv, applied regardless of sex or age. More recent revisions of the NASA Space Cancer Risk model and non-targeted effect scenarios suggest that exploration mission risks may be higher than previously estimated, while uncertainty remains substantial, especially for high-LET radiobiology, mixed-field exposure, and the transfer of terrestrial epidemiological data to the spaceflight setting. Future progress may also involve exploring quantitative imaging biomarkers and tomographic assessments as complementary tools for longitudinal monitoring and early detection of radiation-related tissue changes, although these approaches are not yet validated as components of operational astronaut cancer risk models.”
- 3Cardiovascular risks and hazards associated with deep space exploration.Communications medicine (Brojakowska et al.)Published Jun 23, 2026Checked Oct 4, 2026
“Space flight exposes astronauts to a unique environment characterized by microgravity, ionizing radiation, and other stressors that can profoundly affect the human body. Deep-space exploration-type missions to the Moon (NASA's Artemis and Gateway programs), Mars, and beyond will introduce prolonged exposure to health hazards, including but not limited to isolation and confinement, sleep disruption, and exposure to different types and quantities of particle radiation (i.e., high-energy and atomic number - HZE). There are also logistical implications of traveling farther from low Earth orbit (LEO), including limited access to medical help and supplies. Currently, the known effects of space travel on the cardiovascular system include dysrhythmias, altered vascular compliance, dysautonomia, and induction of a pro-inflammatory state. It is not known how these concerns, and other potentially unknown cardiovascular risks, will manifest during and/or after exploration-type missions. This manuscript comprehensively reviews the cardiovascular disease risks associated with deep space exploration.”
- 4Space radiation health risks to hematopoietic, neural, and gastrointestinal systems in astronauts.Frontiers in public health (Zhang et al.)Published Sep 7, 2026Checked Oct 4, 2026
“Preclinical animal model research indicates that even low doses of space-relevant radiation may induce cognitive decline, memory deficits, anxiety-like behaviors, and neurodegenerative alterations, though these findings remain to be validated in human astronauts. Proposed mechanisms include impaired hippocampal synaptic plasticity, neuroinflammatory activation, and mitochondrial energy metabolism imbalance. Radiation has been shown to compromise the intestinal epithelial barrier, induce intestinal stem cell senescence, and disturb gut microbiome equilibrium in preclinical models. These gastrointestinal alterations may potentially exacerbate neurocognitive dysfunction and promote chronic inflammation via the gut-brain axis, based on mechanistic evidence from animal studies. Currently, there remains an insufficient systematic understanding of the cumulative effects, sex differences, and individual susceptibility associated with long-term low-dose composite radiation exposure. Integrating aerospace medicine is imperative to address these knowledge gaps and safeguard astronaut health during future deep-space missions.”
How it changed
Published 1 time since Oct 4, 2026.
- Version 2Oct 4, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
“Cancer risk: models, standards, and uncertainty” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
“Cardiovascular effects” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
“Central nervous system and gastrointestinal findings” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
Open questions
Will the cognitive, memory, anxiety, and neurodegenerative effects seen in animal models be confirmed in human astronauts, and at what doses?
No answers yet
How will known and unknown cardiovascular risks manifest during and after exploration-type missions beyond low Earth orbit?
No answers yet
What are the cumulative effects, sex differences, and individual susceptibility under long-term low-dose composite radiation exposure?
No answers yet
Can quantitative imaging biomarkers and tomographic assessments be validated for operational monitoring of radiation-related tissue changes?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.